ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 003

Dysregulated Macrophage–Fibroblast Crosstalk Identified by Single-Cell RNA-seq in Juvenile Systemic Scleroderma Skin

Aneri Shethji1, Theresa Hutchins1, Anwesha Sanyal1 and Kathryn Torok2, 1UPMC Childrens Hospital of Pittsburgh, 2University of Pittsburgh, Pittsburgh, PA

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Plenary Abstract Session I

Session Time: 3:00PM-3:15PM

Background/Purpose: Juvenile systemic scleroderma (jSSc) is a rare autoimmune disease characterized by progressive fibrosis and vascular dysfunction. Although jSSc shares important clinical features with adult SSc, including interstitial lung disease in ~40% of patients, reflecting substantial fibrotic burden, its molecular drivers remain poorly defined. In contrast to adult SSc, where multiple single-cell studies have mapped fibroblast heterogeneity, single-cell analyses in jSSc are extremely limited; our group generated the first dataset (n=3 paired, presented in prior meetings). Here we present the largest single-cell dataset to date in jSSc (n=9) and map macrophage–fibroblast communication networks that sustain chronic fibrosis.

Methods: Skin biopsies from 9 jSSc patients and 9 age-matched healthy controls underwent scRNA-seq using the 10x Genomics® Chromium platform. Processed single-cell suspensions were analyzed using Seurat and Harmony for normalization, clustering, and batch correction, with UMAP visualization. Cell-to-cell communication was assessed using NicheNet and CellChat to predict macrophage–fibroblast ligand–receptor interactions and downstream target gene programs.

Results: Eleven transcriptionally distinct fibroblast subsets were identified. COL11A1⁺/POSTN⁺ and a novel STC1⁺/FZD9⁺ fibroblast population were markedly expanded in jSSc and enriched for TGFβ, WNT, and FGF signaling driving extracellular matrix accumulation. The STC1⁺/FZD9⁺ subset showed strong enrichment of pulmonary and hepatic fibrosis signaling pathways. Macrophage clusters MMP19⁺/CTSL⁺ and MERTK⁺ emerged as key profibrotic “sender” populations expressing ligands TGFB1, AREG, and COL6A2, signaling to fibroblast receptors TGFBR1/2, FGFR1/2, and FZD9. NicheNet and CellChat cell communication software revealed an integrated macrophage–fibroblast communication network incorporating TGFβ, FGF, WNT, IGF, NOTCH, and TNF pathways. Accessory activators (ITGAV, THBS1, SDC2) amplified TGFβ engagement, suggesting a self-reinforcing fibroblast-activation loop independent of additional inflammatory input.

Conclusion: This study provides the first expanded single-cell atlas of jSSc skin and identifies a coordinated macrophage-driven signaling circuit sustaining profibrotic fibroblast states. While major pathways parallel adult SSc, the fibroblast populations involved, particularly STC1⁺/FZD9⁺ cells, appear distinct to jSSc. TGFβ–FGF–WNT pathway convergence and accessory activation through ITGAV, THBS1, and SDC2 highlight potential therapeutic targets. By defining juvenile-specific immune–stromal communication, this work advances mechanistic understanding of fibrosis propagation in jSSc and identifies candidate nodes for intervention.

Figure 1. Single-cell characterization of fibroblasts and macrophages in juvenile systemic scleroderma (jSSc) skin.Supporting image 1Fig 1. (A) UMAP plot showing cell-type annotations across all jSSc and healthy skin samples, highlighting major populations including fibroblasts, macrophages, T cells, and endothelial cells. (B) Ingenuity Pathway Analysis of the novel STC1⁺/FZD9⁺ fibroblast cluster demonstrating enrichment of profibrotic pathways, including pulmonary and hepatic fibrosis signaling and TGFβ pathway activation. (C) UMAP of fibroblast subclusters identifying 11 transcriptionally distinct fibroblast subsets based on marker gene expression. (D) Bar plot comparing fibroblast subcluster frequencies between healthy and jSSc samples, showing marked expansion of COL11A1⁺/POSTN⁺ and STC1⁺/FZD9⁺ fibroblasts in jSSc skin. (E) UMAP of macrophage subtypes annotated by key markers, revealing profibrotic subsets including MMP19⁺/CTSL⁺ and MERTK⁺ macrophages. (F) Proportion of macrophage subtypes in healthy versus jSSc skin, demonstrating enrichment of profibrotic macrophages in disease samples.

Figure 2. Macrophage–fibroblast communication networks driving fibrosis in juvenile systemic scleroderma.Supporting image 2Fig 2. (A) CellChat analysis of TGFβ ligand–receptor signaling between macrophage and fibroblast subtypes in jSSc (left) versus healthy (right) skin, demonstrating broader and stronger intercluster connectivity in jSSc. (B) NicheNet ligand–receptor interaction heatmap highlighting strong signaling potential from MMP19⁺/CTSL⁺ macrophages to ANGPTL7⁺ fibroblasts via ligands TGFB1, AREG, and COL6A2 and receptors TGFBR1, FGFR1, and FZD9. (C) Schematic model summarizing the macrophage-driven profibrotic circuit: macrophage-derived TGFβ, FGF, and IGF activate fibroblast ECM programs via WNT signaling, while NOTCH and TNF pathways reinforce chronic fibroblast activation. Accessory activators (ITGAV, THBS1, SDC2) sustain this signaling loop independent of additional inflammatory cues.


Disclosures: A. Shethji: None; T. Hutchins: None; A. Sanyal: None; K. Torok: None.

To cite this abstract in AMA style:

Shethji A, Hutchins T, Sanyal A, Torok K. Dysregulated Macrophage–Fibroblast Crosstalk Identified by Single-Cell RNA-seq in Juvenile Systemic Scleroderma Skin [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/dysregulated-macrophage-fibroblast-crosstalk-identified-by-single-cell-rna-seq-in-juvenile-systemic-scleroderma-skin/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dysregulated-macrophage-fibroblast-crosstalk-identified-by-single-cell-rna-seq-in-juvenile-systemic-scleroderma-skin/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology